BioSyent Inc

(RX:CA)

By |

Profile

Biosyent Inc is a specialty pharmaceutical company engaged in developing pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System and Cysview. The company through its subsidiaries sources acquires or in-licenses pharmaceutical products and markets the products. Geographically all the activities are functioned through the region of Canada.

Contact Information

Website: www.biosyent.com
Email: rhinse@abcourt.com
Main Phone: +1 905 206-0013
Address: 170 Attwell Drive
Address 2: Suite 520
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M9W 5Z5

Issuer Information

Exchange: CDX
CEO: Rene Goehrum
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Biosyent Inc is a specialty pharmaceutical company engaged in developing pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System and Cysview. The company through its subsidiaries sources acquires or in-licenses pharmaceutical products and markets the products. Geographically all the activities are functioned through the region of Canada.

Contact Information

Website: www.biosyent.com
Email: rhinse@abcourt.com
Main Phone: +1 905 206-0013
Address: 170 Attwell Drive
Address 2: Suite 520
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M9W 5Z5

Issuer Information

Exchange: CDX
CEO: Rene Goehrum
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 8.16 $ -0.03 (-0.37%)
Last Price 8.16 Change $ -0.03 Change % -0.37 Tick N/A
Bid 8.16 Bid Size 200.00 Ask 8.20 Ask Size 400.00
Open 8.16 High 8.16 Low 8.16 Prev Close 8.19
Last Trade Volume 3,441 52 Wk Hi 10.26 52 Wk Low 6.93
Market Cap 117.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 14,438,515.00 EPS (TTM) 0.38 PE Ratio 21.60 Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 12.25 12.25 12.25 12.25
Low Target Price Estimate 12.25 12.25 12.25 12.25
Mean Target Price Estimate 12.25 12.25 12.25 12.25
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 11/16/17 11/16/17 11/16/17 11/16/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 2 2 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 2 2 2